Rocket One Inc. RKTO

No annual revenue total was found in ROCKET ONE INC.'s SEC filings.

Rocket One Inc. (RKTO) files with the SEC under industry code 2834, Pharmaceutical Preparations. As of Jun 30, 2026 it held $7.9 million in cash and investments and $5,678 in total debt.

Revenue
—
Net income (TTM)
$-7.88M
+19.5% vs year-ago TTM
Operating cash flow (TTM)
$-10.66M
-20.8% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$-1.40
+62.2% vs year-ago TTM
Dividend per share
None
Shares outstanding
16.26M
+23.4% vs prior year
Net cash
$7.89M
as of Jun 30, 2026
Operating margin
—

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RKTO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Hoboken, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1711786
Former names
Hoth Therapeutics, Inc. (until May 27, 2026)

Other Pharmaceutical Preparations companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Operating income
-$12.4M
-$8.2M
-$8.0M
-$11.1M
-$14.1M
Net income
-$12.5M
-$8.2M
-$8.1M
-$11.4M
-$14.3M
Diluted EPS
-$0.90
-$1.28
-$2.38
-$9.50
—
Operating cash flow
-$9.8M
-$7.0M
-$8.4M
-$9.3M
-$12.1M
Total assets
$7.6M
$7.7M
$10.2M
$7.7M
$11.0M
Total liabilities
$1.5M
$833,906
$704,983
$1.6M
$1.1M
Stockholders' equity
$6.2M
$6.9M
$9.5M
$6.1M
$9.9M
Cash and investments
$6.2M
$7.0M
$9.3M
$6.6M
$10.4M
Total debt
$5,678
$31,075
$55,165
—
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
ARS Annual report to shareholders Oct 23, 2026 Dec 31, 2025
8-K Current report
Other events
Sep 25, 2026 Sep 22, 2026
8-K Current report
Other events
Sep 22, 2026 Sep 22, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Listing notice, Other events
Aug 11, 2026 Aug 6, 2026
8-K Current report
Other events
Jul 31, 2026 Jul 31, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.